首页> 外文期刊>Histology and histopathology >Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas.
【24h】

Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas.

机译:增殖标志物Ki67的表达与阴茎癌的转移和预后的发生,组织学亚型和HPV DNA检测有关。

获取原文
获取原文并翻译 | 示例
           

摘要

Clinical outcome of penile squamous cell carcinoma (PSCC) largely depends on the presence of lymph node metastasis. In search of a valuable marker predicting the risk for metastasis, the expression of Ki67 was investigated immunohistochemically in primary tumors and compared to presence of inguinal lymph node metastasis. As human papilloma virus (HPV) is thought to affect Ki67 expression, we evaluated whether occurrence of HPV DNA correlates to Ki67 score or metastatic potential. Samples originated from patients subjected to resection of invasive SCC of penis. Immunohistochemistry was done on paraffin-embedded sections using a monoclonal antibody against Ki67. After DNA isolation from paraffin embedded tissue the presence of HPV 6/11, HPV 16 and HPV 18 DNA was analyzed by PCR. Statistical analysis was done using two tail unpaired t test and Chi-square test. Four of 28 patients showed a weak Ki67 expression, without displaying lymph node metastasis. Among 17 patients showing an intermediate Ki67 index, eight exhibited metastases while in all seven patients with a strong expression of Ki67 lymph node metastases were found. The median Ki67 expression in metastastic lesions was significantly different (50.3%) from tumors without lymph node metastasis (31.8%) (p=0.024). Furthermore, a correlation between presence of HPV DNA and strong Ki67 expression was determined (p=0.009). Since our study demonstrated a strong Ki67 labeling index significantly associated to positive lymph nodes, we suggest Ki67 expression as a prognostic marker for lymph node metastasis in penile squamous carcinoma.
机译:阴茎鳞状细胞癌(PSCC)的临床结果很大程度上取决于淋巴结转移的存在。为了寻找可预测转移风险的有价值的标志物,免疫组化研究了Ki67在原发性肿瘤中的表达,并与腹股沟淋巴结转移进行了比较。由于人类乳头瘤病毒(HPV)被认为会影响Ki67的表达,因此我们评估了HPV DNA的出现是否与Ki67评分或转移潜能相关。样本来自接受阴茎浸润性SCC切除的患者。使用针对Ki67的单克隆抗体在石蜡包埋的切片上进行免疫组织化学。从石蜡包埋的组织中分离出DNA后,通过PCR分析HPV 6/11,HPV 16和HPV 18 DNA的存在。使用两个尾部不成对t检验和卡方检验进行统计分析。 28例患者中有4例显示Ki67表达较弱,没有淋巴结转移。在表现出中等Ki67指数的17例患者中,有8例出现了转移,而在所有7例中,Ki67淋巴结转移的表达均很强。与无淋巴结转移的肿瘤(31.8%)相比,转移灶中的Ki67表达中位数有显着差异(50.3%)(p = 0.024)。此外,确定了HPV DNA的存在与Ki67的强表达之间的相关性(p = 0.009)。由于我们的研究表明强烈的Ki67标记指数与阳性淋巴结显着相关,因此我们建议Ki67表达可作为阴茎鳞癌淋巴结转移的预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号